Clinical Trials Logo

Ileostomy - Stoma clinical trials

View clinical trials related to Ileostomy - Stoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06344923 Not yet recruiting - Rectal Neoplasms Clinical Trials

Peritoneum and Anterior Rectus Sheath Suturing and Ileostomy

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

In the era of laparoscopy, ileostomy via specimen extraction site has been proposed as a novel approach for temporary ostomy creation to prevent anastomotic leak after laparoscopic low anterior rectal resection. Whether suturing the layer of the peritoneum and anterior rectus sheath affects the safety of this novel approach has not been investigated.

NCT ID: NCT06226753 Not yet recruiting - Anesthesia Clinical Trials

Impact of General Anesthesia v/s Spinal Anesthesia on ERAS Parameters in Intestinal Stoma Reversal

SPIGERAS
Start date: February 2024
Phase: N/A
Study type: Interventional

Randomized, Interventional ,Open labeled, Parallel Assignment and Superiority trial.

NCT ID: NCT04974931 Not yet recruiting - Ileostomy - Stoma Clinical Trials

Application of PREVENA in Reducing Surgical Site Complications Following Reversal of Ileostomy or Colostomy

PRIC
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Surgical site infections (SSI) remain one of the most common complications associated with reversal of ileostomy and colostomy. In addition to having detrimental impacts on the patient's post-operative course, they also pose significant financial ramifications. There have been comparative studies in the use of negative pressure wound therapy in reducing surgical site infections. PREVENA Incision Management System is a type of disposable, customizable and powered negative pressure system designed to help manage and protect surgical incisions and their surrounding environment. It is now commonly used as a surgical wound dressings in the setting of vascular surgeries, post-cesarean infections and colorectal resections. Our study is designed as a randomised controlled trial to examine if PREVERA therapy as a NPWT is more superior than conventional dressings in reducing the rate of surgical site infections.

NCT ID: NCT03941522 Not yet recruiting - Ileostomy - Stoma Clinical Trials

Loop Ileostomy Closure as a 23-hour Stay Procedure, a Multi-center Randomized Controlled Trial

ILEO
Start date: June 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and feasibility of ileostomy closure performed in a 23 hours hospitalization setting, using a multi-center, open-label, randomized controlled trial comparing patients being hospitalized overnight (discharged on the day after surgery) to patients being hospitalized as per the current conventional care after ileostomy closure with both groups following a standardized enhanced recovery after surgery (ERAS) pathway specific to ileostomy closure. Primary outcome will be total length of hospital stay in days and secondary outcomes, measured at 30 days, will include readmission rate, postoperative complication rate minor and severe, postoperative ileus rate, postoperative surgical site infection rate and mortality rate.